Organotherapeutics
OrganoTherapeutics uses cutting-edge human-specific midbrain organoids for the discovery and development of effective drug candidates targeting Parkinson’s disease. We screen new molecules on our proprietary organoids which mimic faithfully the human Parkinson’s disease pathology. OrganoTherapeutics aims at developing new drug candidates against Parkinson’s disease which are tested in state-of-the art 3D patient models. OrganoTherapeutics has developed first own proprietary drug candidates and has access to attractive libraries for further screening.
7-day free trial · no credit card
Verified contacts
7
available on Kipplo
LinkedIn employees
8
1 to 10 range
Open roles
—
no listings
Distinct roles
7
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 7 verified contacts at Organotherapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
7 contacts with verified email or phone · masked until revealed.
- AŽ
Alise Žagare
Lead Project Scientist · Science
EmailPhone - IR
Isabel Rosety
Research and Development Scientist · Other
EmailPhone - MT
Mona Tuzza
Research Technician · Science
EmailPhone - JJ
Javier Jarazo
Co-founder and CSO · General Business & Management
EmailPhone - JS
Jens Schwamborn
Co-founder · General Business & Management
EmailPhone
Showing 5 of 7 verified contacts
Top roles at Organotherapeutics
7 distinct titles indexed · top 7 shown.
- 1co-founder
- 1co-founder and cso
- 1lead project scientist
- 1project manager research specialist
- 1research and development scientist
- 1research technician
- 1team lead scientist
Sign up to unlock all 7 contacts at Organotherapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 7 verified contacts at Organotherapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.